Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson Disease

doi:10.1001/jamaneurol.2018.0345

Editorial

. 2018 Aug 1;75(8):917-920.

doi: 10.1001/jamaneurol.2018.0345.

Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson Disease

Abby L Olsen^{1

2

3}, Trond Riise^{1

4}, Clemens R Scherzer^{1

2

3

5

6}

Affiliations

¹ Precision Neurology Program, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.
³ Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
⁴ Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
⁵ Neurogenomics Laboratory, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.
⁶ Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts.

PMID: 29710184
DOI: 10.1001/jamaneurol.2018.0345

Editorial

Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson Disease

Abby L Olsen et al. JAMA Neurol. 2018.

. 2018 Aug 1;75(8):917-920.

doi: 10.1001/jamaneurol.2018.0345.

Authors

Abby L Olsen^{1

2

3}, Trond Riise^{1

4}, Clemens R Scherzer^{1

2

3

5

6}

Affiliations

¹ Precision Neurology Program, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.
³ Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
⁴ Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
⁵ Neurogenomics Laboratory, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.
⁶ Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts.

PMID: 29710184
DOI: 10.1001/jamaneurol.2018.0345

No abstract available

PubMed Disclaimer

Comment on

Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
Peter I, Dubinsky M, Bressman S, Park A, Lu C, Chen N, Wang A. Peter I, et al. JAMA Neurol. 2018 Aug 1;75(8):939-946. doi: 10.1001/jamaneurol.2018.0605. JAMA Neurol. 2018. PMID: 29710331 Free PMC article.

Cited by

Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study.
Romanowska J, Bjornevik K, Cortese M, Tuominen JA, Solheim M, Abolpour Mofrad A, Igland J, Scherzer CR, Riise T. Romanowska J, et al. Neurology. 2023 Nov 21;101(21):e2068-e2077. doi: 10.1212/WNL.0000000000207899. Epub 2023 Oct 10. Neurology. 2023. PMID: 37816645 Free PMC article.
The evolution of Big Data in neuroscience and neurology.
Dipietro L, Gonzalez-Mego P, Ramos-Estebanez C, Zukowski LH, Mikkilineni R, Rushmore RJ, Wagner T. Dipietro L, et al. J Big Data. 2023;10(1):116. doi: 10.1186/s40537-023-00751-2. Epub 2023 Jul 10. J Big Data. 2023. PMID: 37441339 Free PMC article.
Bilirubin Prevents the TH⁺ Dopaminergic Neuron Loss in a Parkinson's Disease Model by Acting on TNF-α.
Jayanti S, Moretti R, Tiribelli C, Gazzin S. Jayanti S, et al. Int J Mol Sci. 2022 Nov 17;23(22):14276. doi: 10.3390/ijms232214276. Int J Mol Sci. 2022. PMID: 36430754 Free PMC article.

Publication types

Actions
Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson Disease

Affiliations

Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson Disease

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical